SeraCare Team: Leadership
Chief Executive Officer
Charlie Mamrak joined SeraCare as CEO when the Chicago-based private equity firm, Linden Capital Partners, acquired the company in 2012. Before assuming his current role, Mr. Mamrak was an operating partner at Linden where he focused on building the firm’s investment portfolio in life sciences and diagnostics. Prior to Linden, he was CEO of TestPak and then PML MicroBiologicals. Mr. Mamrak has also held general management posts at Fisher Scientific and Sigma-Aldrich in life science research and drug discovery. He has experience progressing from bench level to laboratory and operations management at contract research laboratories including DuPont and Corning. Mr. Mamrak studied biomedical engineering at Pennsylvania State University and earned his BS in biology and chemistry from Moravian College.
Russell Garlick, PhD
Chief Scientific Officer
Russell Garlick joined SeraCare as CSO in 2012 to focus on expanding the company’s technologies, R&D organization, and product development pipeline. Throughout his career he has worked on the development, regulatory approval, and launch of a variety of technologies and assays, including an HIV/AIDS patient management program, molecular genomics technologies, and HIV drug discovery systems. Prior to joining SeraCare, Dr. Garlick was co-founder of Life Sciences Group and served as CEO and CTO of Protein Forest, Inc. He has also held executive R&D positions at PerkinElmer Life Sciences and DuPont NEN Life Sciences. Dr. Garlick earned both his PhD and MS in biomedical sciences, medicinal chemistry from the Barnett Institute at Northeastern University, and his BS in biology from the University of Massachusetts Lowell.
Chief Financial Officer
Paul McEwan joined SeraCare in June of 2015. He has over 25 years of financial experience, predominantly in the life sciences industry. Prior to joining SeraCare, Mr. McEwan served as CFO of Microline Surgical, Inc. His career includes executive management positions at NeuroTherm, Inc., Optos PLC, and BBX, Ltd. Mr. McEwan earned his MBA from the Edinburgh Business School, University of Herriot Watt in Edinburgh, UK and his HNC in accounting from Dundee University in Dundee, UK. He is a member of the Chartered Institute of Management Accountants in the UK and the Institute of Management Accountants in the US.
Bharathi Anekella, PhD
Vice President of Product Development and Technical Operations
Bharathi Anekella joined SeraCare in 2000 and has served in her current role since 2014. She has over 25 years of product development experience in infectious disease, oncology, genetic disease, and recombinant virus. Prior to joining SeraCare, Dr. Anekella was a lead scientist at DNA Technologies where she developed molecular tests. She earned her PhD in microbiology from Osmania University in Hyderabad, India and received a Fogarty Visiting Fellowship to continue her postdoctoral research in the Laboratory of Molecular Virology at the National Cancer Institute. Dr. Anekella has authored and co-authored multiple articles published in peer-reviewed journals.
Trevor W. Brown
Vice President of Clinical Genomics
Trevor Brown joined SeraCare in 2014 after holding leadership positions in global diagnostics strategy at Luminex Molecular Diagnostics, where he established and led their marketing organization. Mr. Brown has rich commercial experience spanning portfolio planning, M&A due diligence, and development and execution of channel strategies to access the growing precision medicine and laboratory-developed testing markets. He previously held several commercial leadership roles at BD Biosciences after working in technical instrument sales at Bio-Rad Laboratories. Mr. Brown earned his MS in cell biology from the University of Alberta and his BS with honors in biochemistry and molecular biology from McMaster University.
Vice President of Molecular and Serology
Joe Kozma came to SeraCare in 2012 from Millipore, where he was vice president of sales at their BioProcess and Technologies division. Mr. Kozma has vast experience working with leading IVD and Biopharmaceutical manufacturers developed throughout his career in the life science and diagnostic industries. Prior to Millipore, he was vice president of global sales for the Celliance division of Serologicals, where he also served as vice president of strategic market development and vice president of corporate sales. Before that, Mr. Kozma was executive vice president of Intergen Company, which he co-founded. He earned his BS in education from Ball State University.
Vice President, Quality and Regulatory Affairs
Hired in 2007 as a validation engineer, Heather Buckley assumed progressively more responsibility before becoming VP of Quality and Regulatory in 2017. Ms. Buckley brings over 20 years of experience in the diagnostics industry to her current leadership role, where her focus has been on aligning strategic initiatives to bring innovative products to domestic and international markets within the changing regulatory environment. Throughout her career, Ms. Buckley has managed quality and regulatory compliance, validation, risk, supplier quality, document control, quality functions related to new product development, and safety. Prior to joining SeraCare, Ms. Buckley held a Senior Research Scientist position in R&D at Siemens Healthcare Diagnostics, developing blood gas analyzers, reagents, and software for point-of-care diagnostic use. She earned her MS in Biotechnology from UMUC and her BS with honors in biology from Northeastern University.
Vice President of Operations
Todd Anderson joined SeraCare in June of 2013. He has over 20 years of experience in the life sciences industry. Prior to joining SeraCare, Mr. Anderson was with Amgen in various roles within Supply Chain & Operations Management. Prior to that, he was in Engineering Services with CDI & Herzog-Hart Engineering, responsible for project management and process engineering for the design and build of pharmaceutical and biotech plants. Mr. Anderson earned an MBA from Bryant University, and a Bachelor’s of Science in Chemical Engineering from Brown University.
Vice President of Global Sales, Clinical Genomics
Erin Feeney joined SeraCare in 2017 after spending 3 years at Medac Pharma where she helped build the initial commercial sales team as Regional Business Director. Prior to Medac, Erin held senior leadership positions at Sequenom Center for Molecular Medicine as well as Monogram Biosciences. Erin has an extensive background of global sales leadership focusing on diagnostics and therapeutics including next generation sequencing, molecular and companion diagnostics, oncology, cardiology, infectious disease, and women's health. She received her BA from University of Pittsburgh with honors.
Senior Director, Data Operations
Lorn Davis joined SeraCare in 2015 to focus on implementing a comprehensive data strategy, including the development and commercialization of products to help customers better manage and derive insight from the company's reference materials and controls. Mr. Davis has in-depth experience in data analytics, visualization, and software development. Prior to joining SeraCare, he worked as a consultant leading data analytics teams engaged with large government and private organizations. Mr. Davis earned his BA in Liberal Arts from St. John's College (NM) and his MBA from Harvard Business School with a focus on technology and entrepreneurship.